Automatic Periodic Stimulation and Continuous Electromyography (EMG) for Facial Nerve Monitoring During Parotidectomy

Overview

About this study

The purpose of this study is to document the safety of the Medtronic automatic periodic stimulating (APS) Electrode Stimulator during a parotidectomy and potentially prevent post-operative facial nerve weakness, which is a relatively common outcome after parotid surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Parotidectomy: Planned parotid gland surgery (superficial or total parotidectomy)
Benign or malignant disease

Exclusion Criteria:

Current pregnancy
Preoperative facial nerve dysfunction
Revision surgery
History of preoperative radiation to the surgical field
Retrograde or extracapsular dissection
Intentional nerve sacrifice (i.e., due to nerve involvement by tumor)
Tumors with proximity to main trunk of facial nerve
Inability to place electrode
Presence of electrode alters surgical technique

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Eric Moore, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Eric Moore, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials